XML 43 R32.htm IDEA: XBRL DOCUMENT v2.4.1.9
FAIR VALUE MEASUREMENTS (Tables)
12 Months Ended
Dec. 31, 2014
FAIR VALUE MEASUREMENTS [Abstract]  
Schedule of financial assets and liabilities measured at fair value on a recurring basis
December 31, 2014
Fair value measurements
Description Fair value Level 1 Level 2 Level 3
       

Investment in Evogene

  $ 1,054 $ 1,054   $ - $ -

Foreign currency derivative contracts

  141 -   141 -
   

Total financial assets

  $ 1,195 $ 1,054   $ 141 $ -

 

 

December 31, 2013


Fair value measurements
Description Fair value Level 1 Level 2 Level 3


Investment in Evogene

  $ 4,565 $ 4,565 $ - $ -

Embedded Derivatives

  (12,431 ) - - (12,431 )
Schedule Of Changes In Level 3 Instruments Measured On A Recurring Basis Using Significant Unobservable Inputs
 


Fair value
of embedded derivatives


 

Balance at January 1, 2013 *)

  $ 6,864

Fair value of Exchange Option within the proceeds under the mAb Funding Agreement

  4,756

Change in fair value of Exchange Option and embedded derivatives within research and development arrangement

  811
 

Balance at December 31, 2013 *)

  12,431
 

Change in fair value of Exchange Option and embedded derivatives within research and development arrangement

  (269 )

Issuance of shares in respect to Termination and Equity Conversion Agreement

  (12,162 )
 

Balance at December 31, 2014

  $ -


Schedule of Fair Value of Outstanding Options to Non-employee
 


Fair value
of outstanding options to non- employee


 

Balance at January 1, 2013

  $ 264

Change in fair value of liability with respect to outstanding options to non- employee

  (104 )

Classification of portion liability with respect to outstanding options to non-employee to additional paid in capital

  (160 )
 

Balance at December 31, 2013

  -